Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 9 | 2025 | 632 | 1.570 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2022 | 44 | 0.740 |
Why?
|
| Circulating Tumor DNA | 3 | 2025 | 39 | 0.560 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 86 | 0.490 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2020 | 946 | 0.390 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 697 | 0.370 |
Why?
|
| Biomarkers, Tumor | 5 | 2025 | 1657 | 0.290 |
Why?
|
| Transcriptome | 3 | 2022 | 1122 | 0.270 |
Why?
|
| Mutation | 4 | 2024 | 6227 | 0.240 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2023 | 60 | 0.200 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2024 | 221 | 0.190 |
Why?
|
| Microsatellite Instability | 1 | 2022 | 40 | 0.190 |
Why?
|
| Manganese | 1 | 2022 | 58 | 0.190 |
Why?
|
| Telomerase | 1 | 2023 | 168 | 0.180 |
Why?
|
| Precision Medicine | 1 | 2025 | 360 | 0.180 |
Why?
|
| Microsatellite Repeats | 1 | 2022 | 236 | 0.180 |
Why?
|
| Wakefulness | 1 | 2022 | 104 | 0.180 |
Why?
|
| Peritoneal Neoplasms | 1 | 2022 | 57 | 0.170 |
Why?
|
| Chromatin | 2 | 2023 | 518 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2016 | 64 | 0.150 |
Why?
|
| HMGA2 Protein | 1 | 2019 | 11 | 0.150 |
Why?
|
| DNA Copy Number Variations | 3 | 2020 | 1032 | 0.150 |
Why?
|
| Stomach Neoplasms | 2 | 2015 | 565 | 0.150 |
Why?
|
| Epithelial Cells | 1 | 2022 | 903 | 0.140 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 1881 | 0.140 |
Why?
|
| Telomere | 1 | 2019 | 222 | 0.130 |
Why?
|
| Lymphocyte Subsets | 1 | 2016 | 39 | 0.130 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2016 | 23 | 0.130 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 1535 | 0.130 |
Why?
|
| Neoplasms | 2 | 2025 | 2955 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2025 | 808 | 0.120 |
Why?
|
| Cachexia | 1 | 2016 | 54 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 1044 | 0.120 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 110 | 0.120 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 89 | 0.120 |
Why?
|
| Seminoma | 1 | 2015 | 10 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 436 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2016 | 362 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 2056 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1304 | 0.110 |
Why?
|
| src Homology Domains | 1 | 2014 | 36 | 0.110 |
Why?
|
| Lymphedema | 1 | 2014 | 18 | 0.110 |
Why?
|
| Humans | 20 | 2025 | 131985 | 0.110 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2014 | 37 | 0.110 |
Why?
|
| Cell Line, Tumor | 5 | 2025 | 3678 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2014 | 51 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2016 | 526 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2016 | 791 | 0.110 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2014 | 100 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 146 | 0.110 |
Why?
|
| Exons | 1 | 2016 | 805 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 131 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2016 | 356 | 0.100 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 346 | 0.100 |
Why?
|
| Liquid Biopsy | 2 | 2023 | 16 | 0.100 |
Why?
|
| Stem Cells | 1 | 2016 | 732 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 1035 | 0.080 |
Why?
|
| Prognosis | 4 | 2025 | 5008 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 2645 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1015 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2020 | 1799 | 0.060 |
Why?
|
| Male | 8 | 2023 | 64910 | 0.060 |
Why?
|
| Female | 8 | 2023 | 70623 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1825 | 0.060 |
Why?
|
| Fluorouracil | 1 | 2025 | 138 | 0.060 |
Why?
|
| Asia | 1 | 2024 | 126 | 0.050 |
Why?
|
| Mice | 4 | 2023 | 18461 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 327 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 1694 | 0.050 |
Why?
|
| Adult | 6 | 2023 | 31547 | 0.050 |
Why?
|
| Spectrum Analysis | 1 | 2022 | 66 | 0.050 |
Why?
|
| Epigenomics | 1 | 2023 | 191 | 0.050 |
Why?
|
| Middle Aged | 6 | 2020 | 28976 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2023 | 167 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2022 | 51 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 719 | 0.050 |
Why?
|
| Phenotype | 2 | 2025 | 4526 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2023 | 6569 | 0.040 |
Why?
|
| Ascites | 1 | 2022 | 102 | 0.040 |
Why?
|
| Cell Line | 2 | 2017 | 2719 | 0.040 |
Why?
|
| Aged | 5 | 2020 | 21415 | 0.040 |
Why?
|
| Machine Learning | 1 | 2025 | 345 | 0.040 |
Why?
|
| Consensus | 1 | 2024 | 649 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2021 | 136 | 0.040 |
Why?
|
| Ligands | 1 | 2022 | 494 | 0.040 |
Why?
|
| Animals | 4 | 2023 | 34789 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2023 | 358 | 0.040 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2019 | 23 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 137 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2023 | 1280 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 4683 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 141 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2023 | 1422 | 0.030 |
Why?
|
| A549 Cells | 1 | 2017 | 49 | 0.030 |
Why?
|
| DNA Replication | 1 | 2019 | 353 | 0.030 |
Why?
|
| K562 Cells | 1 | 2017 | 96 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 158 | 0.030 |
Why?
|
| Epoxy Compounds | 1 | 2016 | 19 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 140 | 0.030 |
Why?
|
| Aging | 1 | 2023 | 1248 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3608 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 126 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 430 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 241 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 1828 | 0.030 |
Why?
|
| Epirubicin | 1 | 2015 | 7 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2017 | 768 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 1647 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 2015 | 14 | 0.030 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2014 | 5 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2025 | 13019 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 73 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2015 | 72 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2014 | 72 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 7100 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 408 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1077 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 198 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2016 | 413 | 0.030 |
Why?
|
| Cadherins | 1 | 2015 | 179 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 174 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 282 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 333 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2015 | 239 | 0.030 |
Why?
|
| Cisplatin | 1 | 2015 | 282 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 199 | 0.030 |
Why?
|
| Point Mutation | 1 | 2014 | 348 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1573 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 514 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 589 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 341 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 309 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2016 | 17391 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2017 | 861 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 687 | 0.020 |
Why?
|
| Metabolomics | 1 | 2016 | 480 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 3351 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 490 | 0.020 |
Why?
|
| DNA Damage | 1 | 2015 | 511 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2015 | 491 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 803 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 534 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 526 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 3830 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 3175 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1359 | 0.020 |
Why?
|
| Exome | 1 | 2015 | 1087 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1721 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 1131 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 3037 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 10941 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2015 | 1122 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1891 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3410 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 2507 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 1977 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 2849 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2015 | 2493 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 9952 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 20535 | 0.010 |
Why?
|